Suzan K. DelBene bought BioAge Labs, Inc (NASDAQ: BIOA)
Suzan K. DelBene (D-WA), a U.S. Representative, has disclosed 1 trade in BioAge Labs, Inc (BIOA) since 2014, a single purchase, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Suzan K. DelBene bought $15,001 - $50,000 of BioAge Labs, Inc (NASDAQ: BIOA) on July 24, 2014. Since that trade, BIOA is up +402.04% against the S&P 500 up +347.95%, an outperformance of +54.08%.
Data updated
Suzan K. DelBene's BIOA trades vs the price
BIOA is up +402.04% since Suzan K. DelBene bought on July 24, 2014, versus +347.95% for the S&P 500.
Performance since this trade
All Suzan K. DelBene BIOA trades
Suzan K. DelBene & BIOA trading FAQ
Is it legal for Suzan K. DelBene to trade BioAge Labs, Inc (BIOA) stock?
Yes. Members of Congress are allowed to trade individual stocks, including BioAge Labs, Inc (BIOA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Suzan K. DelBene buy BIOA?
Suzan K. DelBene disclosed a purchase of $15,001 - $50,000 of BioAge Labs, Inc (BIOA) on July 24, 2014, according to public STOCK Act filings.
How has BIOA performed since Suzan K. DelBene's trade?
Since Suzan K. DelBene bought BIOA on July 24, 2014, the stock is up +402.04%, versus +347.95% for the S&P 500 over the same period, an outperformance of +54.08%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BIOA trades?
Quantellect tracks every disclosed congressional trade in BioAge Labs, Inc (BIOA) on the BioAge Labs, Inc congressional trading page, which aggregates filings across all members of Congress.
Suzan K. DelBene's BIOA tradesAll congressional filings for BioAge Labs, IncSuzan K. DelBene's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.